These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 25017687)
41. [Effectiveness and tolerability of oral liquid ferrous gluconate in iron-deficiency anemia in pregnancy and in the immediate post-partum period: comparison with other liquid or solid formulations containing bivalent or trivalent iron]. Casparis D; Del Carlo P; Branconi F; Grossi A; Merante D; Gafforio L Minerva Ginecol; 1996 Nov; 48(11):511-8. PubMed ID: 9005381 [TBL] [Abstract][Full Text] [Related]
42. Intravenous iron infusion and newer non-dextran formulations. Aung T; Coleman J; Davidson PW; Hetzel DJ; Aung ST N Z Med J; 2021 Apr; 134(1534):118-127. PubMed ID: 33927444 [TBL] [Abstract][Full Text] [Related]
43. Comparison of rates of reported adverse events associated with i.v. iron products in the United States. Bailie GR Am J Health Syst Pharm; 2012 Feb; 69(4):310-20. PubMed ID: 22302256 [TBL] [Abstract][Full Text] [Related]
44. Ferrous iron content of intravenous iron formulations. Gupta A; Pratt RD; Crumbliss AL Biometals; 2016 Jun; 29(3):411-5. PubMed ID: 26956439 [TBL] [Abstract][Full Text] [Related]
45. Hypersensitivity to local anaesthetics--update and proposal of evaluation algorithm. Thyssen JP; Menné T; Elberling J; Plaschke P; Johansen JD Contact Dermatitis; 2008 Aug; 59(2):69-78. PubMed ID: 18759873 [TBL] [Abstract][Full Text] [Related]
49. Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trial. Seid MH; Derman RJ; Baker JB; Banach W; Goldberg C; Rogers R Am J Obstet Gynecol; 2008 Oct; 199(4):435.e1-7. PubMed ID: 18928998 [TBL] [Abstract][Full Text] [Related]
50. Lack of reaction to ferric gluconate in hemodialysis patients with a history of severe reaction to iron dextran. Bastani B; Rahman S; Gellens M ASAIO J; 2002; 48(4):404-6. PubMed ID: 12141472 [TBL] [Abstract][Full Text] [Related]
51. Acute hypersensitivity reaction to ferric gluconate in a premedicated patient. Saadeh CE; Srkalovic G Ann Pharmacother; 2005 Dec; 39(12):2124-7. PubMed ID: 16288068 [TBL] [Abstract][Full Text] [Related]
52. Local and general anesthetics immediate hypersensitivity reactions. Volcheck GW; Mertes PM Immunol Allergy Clin North Am; 2014 Aug; 34(3):525-46, viii. PubMed ID: 25017676 [TBL] [Abstract][Full Text] [Related]
53. [Induction of allergic phenomena by insulin preparations]. Wenig KH; Calap J Munch Med Wochenschr; 1971 Mar; 113(10):345-52. PubMed ID: 4396155 [No Abstract] [Full Text] [Related]
54. Intravenous ferric derisomaltose for the treatment of iron deficiency anemia. Auerbach M; Henry D; DeLoughery TG Am J Hematol; 2021 Jun; 96(6):727-734. PubMed ID: 33580972 [TBL] [Abstract][Full Text] [Related]
55. Iron supplementation in the non-dialysis chronic kidney disease (ND-CKD) patient: oral or intravenous? Macdougall IC Curr Med Res Opin; 2010 Feb; 26(2):473-82. PubMed ID: 20014980 [TBL] [Abstract][Full Text] [Related]
56. Symptoms and danger signs in acute drug hypersensitivity. Bircher AJ Toxicology; 2005 Apr; 209(2):201-7. PubMed ID: 15767037 [TBL] [Abstract][Full Text] [Related]
58. A case report with hypersensitivity to ferrous but tolerance of ferric iron salts. Yilmaz O; Erkasar Citak F J Allergy Clin Immunol Pract; 2016; 4(2):343-4.e1. PubMed ID: 26626063 [No Abstract] [Full Text] [Related]
59. [Hypersensitivity reactions to intravenous iron: an allergist' perspective]. Moi L; Stehlin F; Desseauve D; Ribi C; Muller YD Rev Med Suisse; 2022 Apr; 18(776):639-645. PubMed ID: 35385614 [TBL] [Abstract][Full Text] [Related]
60. Iron isomaltoside 1000: a new intravenous iron for treating iron deficiency in chronic kidney disease. Wikström B; Bhandari S; Barany P; Kalra PA; Ladefoged S; Wilske J; Thomsen LL J Nephrol; 2011; 24(5):589-96. PubMed ID: 21240875 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]